APA

Vitale A., Boccagni P., Kertusha X., Zanus G., D'Amico F., Lodo E., Pastorelli D., Ramirez Morales R., Lombardi G., Senzolo M., Burra P. & Cillo U. (20130131). Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation?. : Transplantation proceedings.

Chicago

Vitale A, Boccagni P, Kertusha X, Zanus G, D'Amico F, Lodo E, Pastorelli D, Ramirez Morales R, Lombardi G, Senzolo M, Burra P and Cillo U. 20130131. Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation?. : Transplantation proceedings.

Harvard

Vitale A., Boccagni P., Kertusha X., Zanus G., D'Amico F., Lodo E., Pastorelli D., Ramirez Morales R., Lombardi G., Senzolo M., Burra P. and Cillo U. (20130131). Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation?. : Transplantation proceedings.

MLA

Vitale A, Boccagni P, Kertusha X, Zanus G, D'Amico F, Lodo E, Pastorelli D, Ramirez Morales R, Lombardi G, Senzolo M, Burra P and Cillo U. Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation?. : Transplantation proceedings. 20130131.